Bisphosphonate treatment in the oim mouse model alters bone modeling during growth

Genetic heterogeneity in osteogenesis imperfecta.

David Sillence, A Senn, D. M. Danks · Journal of Medical Genetics · 1979 · 2.2K citations · Full text

Medicine, Genetics, Bone Metabolism +16

Cyclic Administration of Pamidronate in Children with Severe Osteogenesis Imperfecta

Francis H. Glorieux, Nicholas Bishop, Horacio Plotkin et al. · New England Journal of Medicine · 1998 · 1K citations · Full text

Medicine, Orthopedic Surgery, Bone Metabolism +15

Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure.

Masahiko Sato, W A Grasser, Naoto Endo et al. · Journal of Clinical Investigation · 1991 · 1K citations · Full text

Medicine, Endocrinology, Bone Augmentation +14

Structure-Activity Relationships for Inhibition of Farnesyl Diphosphate Synthase in Vitro and Inhibition of Bone Resorption in Vivo by Nitrogen-Containing Bisphosphonates

James E. Dunford, Keith Thompson, Fraser P. Coxon et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 896 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Pamidronate Treatment of Severe Osteogenesis Imperfecta in Children under 3 Years of Age*

Horacio Plotkin, Frank Rauch, Nicholas Bishop et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 293 citations · Full text

Medicine, Pharmacotherapy, Bone Metabolism +16